Broiler chickens aging 4-6 weeks are susceptible to colibacillosis, which is caused by avian pathogenic E. coli (APEC) (Vandemaele et al., 2002). The disease is typified by acute lethal septicemia or sub-acute fibrinous pericarditis, airsacculitis, salpingitis, and peritonitis (Alexander and Senne, 2008). Colibacillosis is economically significant in poultry industry (Lutful Kabir, 2010). Colistin is a polypeptide antibiotic that is used orally in veterinary medicine to treat or prevent enteritis (EMEA, 2002) especially those caused by E. coli and Salmonella spp. (Collell and Segura, 2013). Colistin acts by altering the bacterial cell membrane's permeability. Electrostatic interactions among the cationic polypeptide and anionic molecules of lipopolysaccharide (LPS) of Gram negative bacteria's outer membrane promote bacterial cell membrane derangement; this type of interaction is an irreversible binding associated with bactericidal activities. Following this process, the cell envelope becomes more permeable, allowing contents to leak out and, eventually, cell death (FAO, 2006; Coria et al., 2011). Furthermore, colistin exhibited strong antiendotoxin activity; Gram negative bacteria endotoxin is the lipid A portion of LPS molecules and colistin attaches to and neutralizes LPS. However, colistin toxicity is reported because of its strong interaction as a cationic drug with highly anionic nerves in the body such as renal nerves, cochlear and that's of skeletal muscles nerves. Permanent or irreversible binding causes nephrotoxicity and neurotoxicity (Lim et al., 2010). Hence, to overcome these problems, colistin-loaded niosomes has been developed. Niosomes are a sort of nanoparticles that include cholesterol and nonionic surfactants. To enhance the delivery of medications that are water-soluble, like colistin, niosomes are being considered as a potential pharmacokinetic system (Manosroi et al., 2003; Bnyan et al., 2018). The selectivity, efficiency, and bioavailability of drug are all enhanced by niosomes (Manosroi et al., 2003; Nowroozi et al., 2018). Researchers have demonstrated that niosomes enhance target-site uptake, prolong circulation time, decrease toxicity and strength stability of medication (Manosroi et al., 2003; Nowroozi et al., 2018). To ensure that the generated niosomes have a very negative charge, the charge inducer dihexadecyl phosphate was used (Waddad et al., 2013; Bnyan et al., 2018). The present work aimed to formulate a parenteral colistin-loaded niosomes (CLN) to improve the efficacy and decrease the toxicity of colistin as a potential treatment against multi-drug resistant avian pathogenic E.coli in broiler chicks.
Read full abstract